Fatty acid derivative anticonvulsants

U-S 181 Pill - beige oval, 15mm

Pill with imprint U-S 181 is Beige, Oval and has been identified as Divalproex Sodium Delayed-Release 250 mg. It is supplied by Upsher-Smith Laboratories, Inc.

Divalproex sodium is used in the treatment of Bipolar Disorder; Mania; Epilepsy; Migraine Prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Divalproex sodium (Divalproex sodium [ dye-val-pro-ex ])-U-S 181-250 mg-Beige-Oval
Divalproex sodium (Divalproex sodium [ dye-val-pro-ex ])-U-S 181-250 mg-Beige-Oval

Divalproex sodium
Generic Name: divalproex sodium [ dye-val-pro-ex ]
Imprint: U-S 181
Strength: 250 mg
Color: Beige
Size: 15.00 mm
Shape: Oval
Availability: Prescription only
Drug Class: Fatty acid derivative anticonvulsants
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00245-0181 (Discontinued)
Inactive Ingredients: Methacrylic acid - ethyl acrylate copolymer (1:1) type a, Povidone, Corn starch, Silicon dioxide, Sodium bicarbonate, Sodium lauryl sulfate, Magnesium silicate, Triethyl citrate, Titanium dioxide, Vanillin, FD&C Yellow No. 6, Ferric oxide red,
Latest News
Related Drugs